WallStreetZenWallStreetZen

NASDAQ: ERNA
Ernexa Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Ernexa Therapeutics earnings were -$11.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ERNA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$5.5M, up 264.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ERNA reported annual earnings of -$14.1M, with -68.4% growth.

ERNA earnings history

Current Revenue
$0.0
Current Earnings
-$11.4M
Current Profit Margin
0%

ERNA Return on Equity

Current Company
-264.1%
Current Industry
-146.2%
Current Market
5.2%
ERNA's Return on Equity (-264.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ERNA Return on Assets

Current Company
-151.4%
Current Industry
-12.4%
ERNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ERNA announces earnings.

ERNA Return on Capital Employed

Current Company
-161.56%
Current Industry
-8.9%
ERNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ERNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ERNA-$11.17M-$11.40MN/A-$25.90
ICU-$11.87M-$11.90MN/A-$3.86
CTXR-$34.26M-$35.89MN/A-$2.56
BLRX$628.00k-$1.18MN/A$0.00
NCELN/A-$8.30MN/A-$2.16
View Top Biotech Stocks

Ernexa Therapeutics Earnings Reports & History FAQ

What were Ernexa Therapeutics's earnings last quarter?

Ernexa Therapeutics (NASDAQ: ERNA) reported Q1 2026 earnings per share (EPS) of -$6.95, up 87.97% year over year. Total ERNA earnings for the quarter were -$5.51 million. In the same quarter last year, Ernexa Therapeutics's earnings per share (EPS) was -$57.76.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.

Is Ernexa Therapeutics profitable or losing money?

As of the last Ernexa Therapeutics earnings report, Ernexa Therapeutics is currently losing money. Ernexa Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$11.39 million, a 75.3% decrease year over year.

What was ERNA's earnings growth in the past year?

As of Ernexa Therapeutics's earnings date in Q2 2026, Ernexa Therapeutics's earnings has grown year over year. ERNA earnings in the past year totalled -$11.40 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.